Natera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). 

CEO
Stephen Leonard Chapman
CEOStephen Leonard Chapman
Employees
6,140
Employees6,140
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2003
Founded2003
Employees
6,140
Employees6,140

NTRA Key Statistics

Market cap
28.37B
Market cap28.37B
Price-Earnings ratio
-130.14
Price-Earnings ratio-130.14
Dividend yield
Dividend yield
Average volume
1.15M
Average volume1.15M
High today
High today
Low today
Low today
Open price
$190.34
Open price$190.34
Volume
0.00
Volume0.00
52 Week high
$256.36
52 Week high$256.36
52 Week low
$125.38
52 Week low$125.38

Stock Snapshot

The current Natera(NTRA) stock price is $199.99, with a market capitalization of 28.37B. The stock trades at a price-to-earnings (P/E) ratio of -130.14.

On 2026-04-01, Natera(NTRA) stock opened at $190.34, reached a high of —, and a low of —.

Natera(NTRA) shares are trading with a volume of 0, against a daily average of 1.15M.

During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $256.36 at its peak.

During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $256.36 at its peak.

NTRA News

Simply Wall St 2h
Exploring 3 High Growth Tech Stocks In The US Market

In the last week, the United States market has stayed flat but is up 16% over the past year, with earnings forecasted to grow by 15% annually. In this context,...

Exploring 3 High Growth Tech Stocks In The US Market
Simply Wall St 3h
Signatera Data in Older Breast Cancer Patients Could Be A Game Changer For Natera

Natera, Inc. recently reported Clinical Cancer Research data showing its Signatera molecular residual disease test helped older women with early-stage ER+/HER2-...

Signatera Data in Older Breast Cancer Patients Could Be A Game Changer For Natera
Benzinga 20h
Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery

• Natera stock is showing exceptional strength. What’s fueling NTRA momentum? Signatera Study: MRD-Negative Patients Skip Surgery The study published in Clinica...

Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery

Analyst ratings

90%

of 21 ratings
Buy
90.5%
Hold
9.5%
Sell
0%

More NTRA News

Simply Wall St 4d
A Look At Natera Valuation After Recent Share Price Weakness

Advertisement Stock performance snapshot Natera (NTRA) has drawn investor attention after a period of weaker share performance, with the stock down about 7% o...

A Look At Natera Valuation After Recent Share Price Weakness
Simply Wall St 7d
Is It Time To Reassess Natera After Its Recent Share Price Pullback

This article examines whether Natera, at around US$197 a share, still aligns with its underlying worth or whether expectations have already been priced in. The...

Is It Time To Reassess Natera After Its Recent Share Price Pullback

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.